Given this, it could be a more convenient option for patients seeking greater LDL-C reductions, with less strict adherence necessary. It is imperative to elucidate the real-world impacts of inclisiran on LDL-C in the United States given its potentially massive population benefit; however, literature is lacking on the subject. Insights from a real-world experience with inclisiran at a large United States lipid clinic. Halpern L. Inclisiran with LLT reduces LDL-C in hypercholesterolemia without inducing muscle pain. High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany.